Abstract
Burkholderia cepacia is a rare cause of sepsis in newborns and its transmission involves human contact with heavily contaminated medical devices and disinfectants. The authors aimed to determine epidemiology, clinical features, antibiotic sensitivity pattern, complications and outcome of blood culture proven B. cepacia infections in 12 neonates. All neonates were outborn, 5 preterm and 7 term. B. cepacia was isolated from blood in all and concurrently from CSF in three neonates. Lethargy and respiratory distress (41.7 %) were major presenting features. Five newborns (41.7 %) required mechanical ventilation for 3–7 d. Highest bacterial susceptibility was observed for meropenem (100 %), followed by cefoperazone-sulbactam, piperacillin-tazobactam, sulfamethoxazole-trimethoprim (all 83 %), ceftazidime (75 %) and ciprofloxacin (42 %). Piperacillin-tazobactam, ciprofloxacin and cotrimoxazole either singly or in combination led to complete recovery of 11 (91.7 %) newborns; one developed hydrocephalus. Eight of nine infants who completed 6 mo follow up were normal. Prompt recognition and appropriate antibiotic therapy for B. cepacia infection results in complete recovery in majority.
References
Forbes BA, Sahm DF, Weissfeld AS. Pseudomonas, Burkholderia and similar organisms. In: Forbes BA, Sahm DF, Weissfeld AS, editors. Bailey and Scott’s diagnostic microbiology. 12th ed. St. Louis: Elsevier; 2007. p. 340–50.
Winn Jr WC, Allen SD, Janda WM, Koneman E, Procorp G, Schreckenberger P, et al. The nonfermentative Gram-Negative bacilli. In: Winn Jr WC, Allen SD, Janda WM, Koneman E, Procorp G, Schreckenberger P, Woods GL, editors. Koneman’s Color atlas and textbook of diagnostic microbiology. 6th ed. Philadelphia: Lippincott Williams and Wilkins; 2006. p. 326–8.
Kuzumoto K, Kubota N, Ishii K, Yumoto K, Ogiso Y, Nakamura T, et al. Successful cessation of transmitting healthcare associated infections due to Burkholderia cepacia complex in a neonatal intensive care unit in a Japanese children’s hospital. Eur J Med Res. 2011;16:537–42.
Viswanathan R, Singh AK, Ghosh C, Dasgupta S, Mukherjee S, Basu S. Profile of neonatal septicaemia at a district-level sick newborn care unit. J Health Popul Nutr. 2012;30:41–8.
Sundaram V, Kumar P, Dutta S, Mukhopadhyay K, Ray P, Gautam V, et al. Blood culture confirmed bacterial sepsis in neonates in a North Indian tertiary care centre: changes over the last decade. Jpn J Infect Dis. 2009;62:46–50.
Clinical Laboratory Standards Institute. 2006. Performance standards for antimicrobial disk susceptibility tests; Approved standard-9th ed. CLSI document M2-A9.26:1, Clinical Laboratory Standards Institute, Wayne, PA.
Hancock RE. Resistance mechanism in Pseudomonas aeruginosa and other nonfermentative gram-negative bacteria. Clin Infect Dis. 1998;27:93–9.
Gautam V, Singhal L, Ray P. Burkholderia cepacia complex: beyond pseudomonas and acinetobacter. Indian J Med Microbiol. 2011;29:4–12.
Avgeri SG, Matthaiou DK, Dimopoulos G, Grammatikos AP, Falagas ME. Therapeutic options for Burkholderia cepacia infections beyond co-trimoxazole: a systematic review of the clinical evidence. Int J Antimicrobial Agents. 2009;33:394–404.
Jacquier H, Monnier AL, Carbonnelle E, Corvec S, Illiaquer M, Bille E, et al. In vitro antimicrobial activity of “last resort” antibiotics against unusual non fermenting gram negative bacilli clinical isolates. Microb Drug Resist. 2012;18:396–401.
Contributions
SP: Involved in data collection and preparation of the manuscript; RBY and LEL: Involved in patient treatment, supervision of data collection and critical approval of the manuscript; JP and VVS: Involved in helping manuscript preparation; VKE: Provided expert microbiological inputs; SM: Involved in data collection. LEL will act as guarantor for this paper.
Conflict of Interest
None.
Source of Funding
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Patra, S., Bhat Y, R., Lewis, L.E. et al. Burkholderia cepacia Sepsis Among Neonates. Indian J Pediatr 81, 1233–1236 (2014). https://doi.org/10.1007/s12098-014-1473-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12098-014-1473-9